Boeing L, Murray V, Pelosi A, McCabe R, Blackwood D, Wrate R. Adolescent-onset psychosis: prevalence, needs and service provision. Br J Psychiatry. 2007;190:18–26.
Lay B, Blanz B, Hartmann M, Schmidt MH. The psychosocial outcome of adolescent-onset schizophrenia: a 12-year followup. Schizophr Bull. 2000;26(4):801–16.
Article CAS PubMed Google Scholar
Hui CL, Li AW, Leung CM, Chang WC, Chan SK, Lee EH, Chen EY. Comparing illness presentation, treatment and functioning between patients with adolescent- and adult-onset psychosis. Psychiatry Res. 2014;220(3):797–802.
Kelleher I, Cannon M. Psychotic-like experiences in the general population: characterizing a high-risk group for psychosis. Psychol Med. 2011;41(1):1–6.
Article CAS PubMed Google Scholar
Paus T, Keshavan M, Giedd JN. Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci. 2008;9(12):947–57.
Article CAS PubMed PubMed Central Google Scholar
Ballageer T, Malla A, Manchanda R, Takhar J, Haricharan R. Is adolescent-onset first-episode psychosis different from adult onset? J Am Acad Child Adolesc Psychiatry. 2005;44(8):782–9.
Baeza I, de la Serna E, Mezquida G, Cuesta MJ, Vieta E, Amoretti S, Lobo A, Gonzalez-Pinto A, Diaz-Caneja CM, Corripio I, et al. Prodromal symptoms and the duration of untreated psychosis in first episode of psychosis patients: what differences are there between early vs. adult onset and between schizophrenia vs. bipolar disorder? Eur Child Adolesc Psychiatry. 2024;33(3):799–810.
Baeza I, de la Serna E, Amoretti S, Cuesta MJ, Diaz-Caneja CM, Mezquida G, Lobo A, Gonzalez-Pinto A, Corripio I, Vieta E et al. Premorbid Characteristics as predictors of early onset Versus Adult Onset in patients with a first episode of psychosis. J Clin Psychiatry 2021, 82(6):21m13907.
Veru F, Jordan G, Joober R, Malla A, Iyer S. Adolescent vs. adult onset of a first episode psychosis: impact on remission of positive and negative symptoms. Schizophr Res. 2016;174(1–3):183–8.
Zhang T, Cui H, Wei Y, Tang X, Xu L, Hu Y, Tang Y, Chen T, Li C, Wang J. Neurocognitive assessments are more important among adolescents than adults for Predicting psychosis in clinical high risk. Biol Psychiatry Cogn Neurosci Neuroimaging. 2022;7(1):56–65.
Cui H, Giuliano AJ, Zhang T, Xu L, Wei Y, Tang Y, Qian Z, Stone LM, Li H, Whitfield-Gabrieli S, et al. Cognitive dysfunction in a psychotropic medication-naive, clinical high-risk sample from the ShangHai-At-Risk-for-psychosis (SHARP) study: associations with clinical outcomes. Schizophr Res. 2020;226:138–46.
Seidman LJ, Shapiro DI, Stone WS, Woodberry KA, Ronzio A, Cornblatt BA, Addington J, Bearden CE, Cadenhead KS, Cannon TD, et al. Association of Neurocognition with Transition to psychosis: baseline functioning in the second phase of the North American Prodrome Longitudinal Study. JAMA Psychiatry. 2016;73(12):1239–48.
Article PubMed PubMed Central Google Scholar
Mensi MM, Orlandi M, Casini E, Catalan A, de Pablo GS, Fusar-Poli P, Borgatti R. Neurocognition and functioning in adolescents at clinical high risk for psychosis. Child Adolesc Psychiatry Ment Health. 2023;17(1):22.
Article PubMed PubMed Central Google Scholar
Grover S, Sahoo S, Nehra R. A comparative study of childhood/adolescent and adult onset schizophrenia: does the neurocognitive and psychosocial outcome differ? Asian J Psychiatr. 2019;43:160–9.
De la Serna E, Puig O, Mezquida G, Moreno-Izco L, Merchan-Naranjo J, Amoretti S, Ruiz P, Gonzalez-Pinto A, Molina-Garcia M, Corripio I, et al. Relationship between cognition and age at onset of first-episode psychosis: comparative study between adolescents, young adults, and adults. Eur Child Adolesc Psychiatry. 2023;32(4):639–49.
White T, Ho BC, Ward J, O’Leary D, Andreasen NC. Neuropsychological performance in first-episode adolescents with schizophrenia: a comparison with first-episode adults and adolescent control subjects. Biol Psychiatry. 2006;60(5):463–71.
Arango C, Fraguas D, Parellada M. Differential neurodevelopmental trajectories in patients with early-onset bipolar and schizophrenia disorders. Schizophr Bull. 2014;40(Suppl 2):S138–146.
Lee H, Dvorak D, Kao HY, Duffy AM, Scharfman HE, Fenton AA. Early cognitive experience prevents adult deficits in a neurodevelopmental schizophrenia model. Neuron. 2012;75(4):714–24.
Article CAS PubMed PubMed Central Google Scholar
Kuo SS, Musket CW, Rupert PE, Almasy L, Gur RC, Prasad KM, Roalf DR, Gur RE, Nimgaonkar VL, Pogue-Geile MF. Age-dependent patterns of schizophrenia genetic risk affect cognition. Schizophr Res. 2022;246:39–48.
Article PubMed PubMed Central Google Scholar
James A, Joyce E, Lunn D, Hough M, Kenny L, Ghataorhe P, Fernandes HM, Matthews PM, Zarei M. Abnormal frontostriatal connectivity in adolescent-onset schizophrenia and its relationship to cognitive functioning. Eur Psychiatry. 2016;35:32–8.
Article CAS PubMed Google Scholar
Zhao J, Zhang Y, Liu F, Chen J, Zhao J, Guo W. Abnormal global-brain functional connectivity and its relationship with cognitive deficits in drug-naive first-episode adolescent-onset schizophrenia. Brain Imaging Behav. 2022;16(3):1303–13.
Howes OD, McDonald C, Cannon M, Arseneault L, Boydell J, Murray RM. Pathways to schizophrenia: the impact of environmental factors. Int J Neuropsychopharmacol. 2004;7(Suppl 1):S7–13.
Article CAS PubMed Google Scholar
Puig O, Penades R, Baeza I, De la Serna E, Sanchez-Gistau V, Bernardo M, Castro-Fornieles J. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry. 2014;53(8):859–68.
Wykes T, Newton E, Landau S, Rice C, Thompson N, Frangou S. Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophr Res. 2007;94(1–3):221–30.
Fagerlund B, Pagsberg AK, Hemmingsen RP. Cognitive deficits and levels of IQ in adolescent onset schizophrenia and other psychotic disorders. Schizophr Res. 2006;85(1–3):30–9.
Hanna RC, Shalvoy A, Cullum CM, Ivleva EI, Keshavan M, Pearlson G, Hill SK, Sweeney JA, Tamminga CA, Ghose S. Cognitive function in individuals with psychosis: moderation by adolescent Cannabis Use. Schizophr Bull. 2016;42(6):1496–503.
Article PubMed PubMed Central Google Scholar
Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76.
Article CAS PubMed Google Scholar
Kern RS, Gold JM, Dickinson D, Green MF, Nuechterlein KH, Baade LE, Keefe RS, Mesholam-Gately RI, Seidman LJ, Lee C, et al. The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. Schizophr Res. 2011;126(1–3):124–31.
Kern RS, Nuechterlein KH, Green MF, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Mintz J, Seidman LJ, et al. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry. 2008;165(2):214–20.
Shi C, He Y, Cheung EF, Yu X, Chan RC. An ecologically valid performance-based social functioning assessment battery for schizophrenia. Psychiatry Res. 2013;210(3):787–93.
Hardin AP, Hackell JM, Committe on practice, Ambulatory medicine. Age Limit of Pediatrics. Pediatr. 2017;140(3):e20172151.
Diedenhofen B, Musch J. Cocor: a comprehensive solution for the statistical comparison of correlations. PLoS ONE. 2015;10(3):e0121945.
留言 (0)